The pharmaceutical industry is undergoing a data revolution, and medical affairs sits at the centre of this transformation. In a recent ARCS webinar, I had the opportunity to share insights into why data is now one of the most strategic assets organisations hold—and why building a robust foundation for its governance and use is no longer optional, but essential.

Historically, medical affairs functions operated in a largely reactive mode—providing scientific information, responding to medical enquiries, and supporting regulatory processes. The data used in this context was typically internal: clinical trial results, regulatory submissions, and published literature, often managed in silos and accessed on an as-needed basis.

But times have changed. Today, data is no longer just a record of what has happened. It is a compass pointing towards what is possible. Medical affairs teams are increasingly expected to deliver strategic insights, enhance stakeholder engagement, and improve patient outcomes—all of which hinge on timely, accurate, and accessible data.

To achieve this, organisations must shift from reactive data use to a more proactive, predictive model. This means embracing a broad spectrum of data sources, including real-world and real-time data, patient and healthcare professional (HCP) insights, and digital engagement analytics. But more importantly, it requires a deliberate and structured approach to data governance.

Data governance, simply put, is the oversight of how data is managed across its lifecycle—from creation and storage to sharing and eventual disposal. It encompasses policy setting, role definition, quality monitoring, access controls, and compliance. It's not about running reports or coding queries; it’s about ensuring data is trustworthy, protected, and strategically leveraged according to defined principles.

In the medical affairs context, data governance is both an enabler and a safeguard. Done well, it ensures that data used to make decisions is accurate, timely, and relevant. It also helps organisations meet privacy obligations, reduce risk, and build credibility with both internal and external stakeholders.

One of the key tools in assessing an organisation’s capability is the data maturity model. These models outline a progression from initial, disorganised data practices through to fully optimised, predictive systems. Many organisations today sit somewhere in the middle—aware of the value of data but not yet realising its full potential. Progressing along this spectrum requires not just technology, but cultural change. Executive support is critical, as is cross-functional collaboration.

Medical affairs professionals also need to advocate for data literacy within their teams. Understanding the fundamental components and principles of data governance—such as establishing clear accountability for data, ensuring transparency in data handling, maintaining data integrity through robust quality dimensions, managing metadata effectively to provide context, and tracking data provenance & lineage empowers teams to ask the right questions, spot inconsistencies, and use data responsibly.

Technology plays a supporting role. Platforms like Microsoft Purview and secure data enclaves are making it easier to manage data access and usage across organisations. However, no tool can replace the need for human judgement, accountability, and clear governance structures built on sound principles.

As we look to the future, the role of artificial intelligence and machine learning in medical affairs will continue to grow. These technologies promise new ways to interpret complex datasets and support decision-making. But their effectiveness hinges on one key input: high-quality, well-governed data.

If data is the fuel for innovation, then data governance is the engine that ensures it runs smoothly, safely, and purposefully. For medical affairs teams striving to be strategic partners within their organisations, investing in this foundation isn’t just beneficial—it’s vital.